The CE-marked test detects two biomarkers of infection in peritoneal dialysis waste fluid using a lateral flow immunoassay system.
The deal covers SpeeDx's line of multiplexed PlexPCR and ResistancePlus tests in the UK and Ireland.
A brief recap of Diagnostics news the week of Apr 20, 2018: Boston Scientific, Interpace, Human Longevity, CareDX, OpGen SeraCare Life Sciences, Omega Diagnostics, MDxHealth's SelectMDx.
The companies are aiming to develop and establish clinical operation for the assays in Japan, where Hitachi said there is growing demand for such tests.
ALK will market Rellergen's Bio-IC lab-on-a-chip technology to more than 190 hospitals in China. The technology uses a blood sample to screen up to 20 different allergens.
OncoDNA has recently signed a number of distribution agreements for its products, which include the OncoTrace and OncoSelect liquid biopsy tests.
Streck inked a three-year agreement with Van Xuan, a distributor with customers in public hospitals, private clinics, and pharma and manufacturing labs.
The companies will initially plan to acquire the required regulatory approvals in India for the Genedrive HCV ID kit.
Aker Bio's test is used for determining whether a patient being treated with heparin may be developing heparin-induced thrombocytopenia.
Under the agreement, Beckman Coulter will distribute the full range of Technopath Multichem QC products in more than 100 countries.